A new global survey shows that 56.6 percent of Indian survey participants aged 50 and above know little to nothing about shingles, although more than 90 pc of adults above 50 years have this virus in ...

New findings from a recent white paper highlight the economic and healthcare burden posed by Respiratory Syncytial Virus (RSV ...

The NSE Nifty 50 ended 254.65 points or 1.15% higher at 22,337.30, while the BSE Sensex closed 740.30 points or 1.01% up at ...

Rare Disease Day, an annual gathering hosted by the FDA and National Institutes of Health, was postponed. Medicare spending on 10 diabetes drugs, including popular GLP-1s, more than quadrupled over a ...

LONDON, - British drugmaker GSK will no longer set diversity targets, it said on Thursday, as it became the latest company to scale back or abandon such goals in response to the U.S. president's ...

Feb 13 (Reuters) - India's GlaxoSmithKline Pharmaceuticals (GLAX.NS), opens new tab reported a higher adjusted third-quarter profit on Friday, led by sustained demand for its respiratory drugs and ...

The market was pleased with the recent earnings report from GSK plc (LON:GSK), despite the profit numbers being soft. However, we think the company is showing some signs that things are more ...

GSK has announced a 50/50 joint venture with ... six-in-one combination paediatric vaccine to help protect children in India and other developing countries from polio and other infectious diseases.

adjuvanted), as the company spearheads the expansion of adult immunization in India. Commenting on the results, Bhushan Akshikar, Managing Director of GlaxoSmithKline Pharmaceuticals Limited ...

(Reuters) - India's GlaxoSmithKline Pharmaceuticals reported a higher adjusted third-quarter profit on Friday, led by sustained demand for its respiratory drugs and antibiotic Augmentin. The Indian ...

Advt Dr. Shalini Menon, Medical Director at GSK India, noted, “As we age, our natural ability to fight disease diminishes, making us more susceptible to various illnesses like shingles.